<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001658'>Myocardial infarction</z:hpo> and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> are associated at the population level and in autoptic studies </plain></SENT>
<SENT sid="1" pm="."><plain>Glycated <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (apoB) is a risk factor for the development of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The association of glycated apoB with dysplastic and neoplastic colorectal tissue was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: Forty-eight consecutive surgical specimens, 26 colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 22 colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, retrieved from the archives of the Pathologic <z:mp ids='MP_0000002'>Anatomy</z:mp> Department of our institution, were examined </plain></SENT>
<SENT sid="4" pm="."><plain>The tissue content of glycated apoB was determined using a monoclonal antibody </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Glycated apoB was detected in 27% of the <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 45% of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue, but only in 18% of the <z:mpath ids='MPATH_458'>normal</z:mpath> tissue near the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> site </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Glycated apoB is associated with dysplastic and even more so with neoplastic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue </plain></SENT>
</text></document>